Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | GRM5 | P41594 | 1/20 | 0.30 |
| ▸ | GRM1 | Q13255 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | SLC6A7 | Q99884 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11723706 | 0.87 | CYP2C19 (0.36) | RXFP1CYP2C19 | |
| SCHEMBL11725800 | 0.82 | CYP2C19 (0.36) | RXFP1CYP2C19 | |
| SCHEMBL11842731 | 0.82 | SMN1; SMN2 (0.40) | NPC1RAB9AHTT | |
| SCHEMBL11843203 | 0.81 | CYP2C19 (0.35) | RXFP1CYP2C19 | |
| SCHEMBL11732251 | 0.77 | RXFP1 (0.34) | RXFP1NPC1RAB9ACYP2C19HTT | |
| SCHEMBL11777882 | 0.77 | MAPT (0.40) | NPC1RAB9ACYP2C19MEN1 | |
| SCHEMBL11850406 | 0.76 | CYP2C19 (0.39) | CYP2C19 | |
| SCHEMBL11740246 | 0.73 | SMN1; SMN2 (0.32) | CYP2C19 | |
| SCHEMBL11728528 | 0.71 | LMNA (0.39) | RXFP1CYP2C19 | |
| SCHEMBL11725247 | 0.71 | LMNA (0.39) | RXFP1CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4065567-A | Substituted nitroimidazolyl thiadiazoles and oxadiazoles as antibacterial agents and growth promoting compounds | AMERICAN CYANAMID COMPANY (US) | 1977-12-27 | — | — | US | disclosed |